Economia

Transaction in Own Shares

28 thFebruary 2025 PayPoint plc ("PayPoint" or the "Company") Transaction in Own SharesThe Company announces today it has purchased the following number of its ordinary shares of £0.00333 each through Investec Bank plc (“Investec”). Ordinary Shares Date of purchase:27 thFebruary 2025Aggregate number of ordinary shares purchased:11,983Lowest price per share (pence):641.00Highest price per share (pence):662.00Weighted average price per day (pence):...
Nasdaq GlobeNewswire
28/02/2025

AB KN Energies will hold a Webinar regarding unaudited financial results for the…

On the 28 thof February 2025 at 11:00 (EET) AB KN Energies will hold a conference webinar for its shareholders, investors, mass media representatives and other stakeholders. The presentation will be held in English. The webinar will be hosted by KN Chief Financial Officer Tomas Tumėnas who will introduce the Group's financial results for the twelve months of 2024 and will answer the participant questions.Webinar presentation is enclosed. Tomas Tumėnas, Chief Financial Officer, +370...
Nasdaq GlobeNewswire
28/02/2025

AB KN Energies unaudited financial information for the twelve months of 2024

AB KN Energies (hereinafter – KN, the Company) announces the unaudited consolidated (hereinafter – the Group) and separate financial results for the twelve months ended 31 December 2024.Key financial indicators for the 1-12 months of 2024: EUR millionsGroupCompany 1-12 months of 20241-12 months of 20231-12 months of 20241-12 months of 2023 Revenue93.783.589.480.4EBITDA49.335.646.934.3Net profit (loss)15.413.213.812...
Nasdaq GlobeNewswire
28/02/2025

FRO – Fourth Quarter and Full Year 2024 Results

FRONTLINE PLC REPORTS RESULTS FOR THE FOURTH QUARTER ENDED DECEMBER 31, 2024 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three and twelve months ended December 31, 2024: HighlightsProfit of $66.7 million, or $0.30 per share for the fourth quarter of 2024.Adjusted profit of $45.1 million, or $0.20 per share for the fourth quarter of 2024.Declared a cash dividend of $0.20 per share for the fourth quarter of 2024...
Nasdaq GlobeNewswire
28/02/2025

dsm-firmenich publishes 2024 Integrated Annual Report

Press Release dsm-firmenich publishes 2024 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 28, 2025dsm-firmenich today announces the publication of its 2024 Integrated Annual Report (IAR).The 2024 IAR contains detailed insights into dsm-firmenich's financial and non-financial progress during its first full year as an integrated company. Through its highly innovative portfolio of nutritional, natural and renewable ingredients, together with...
Nasdaq GlobeNewswire
28/02/2025

Molecular Partners Announces Participation at Upcoming Investor Conferences and…

Participation in fireside chats at TD Cowen and Leerink healthcare conferencesCall on 2024 financial results on March 7 at 2.00 pm CET (8.00 am ET) ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb.28, 2025(GLOBE NEWSWIRE) --Molecular PartnersAG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced its attendance and presentations at...
Nasdaq GlobeNewswire
28/02/2025

Novaturas earned profit of EUR 2.6 mln. in the last quarter and improved its…

According to unaudited data, Novaturas Group recorded revenue growth and profit in the last quarter of 2024. Between October and December, the company generated revenues of EUR 48 mln., which is an increase of 16.6% compared to the corresponding period of the previous year. The net operating profit of the company was positive at EUR 2.6 mln. compared to a loss of EUR 3 mln. in the fourth quarter of 2023. The EBITDA for October–December accounts for EUR 3.3 mln. (compared to EUR -1.5 mln. in Q4…
Nasdaq GlobeNewswire
28/02/2025

Brookfield Corporation Announces Pricing of $500 Million Notes Due 2055

The notes will be issued by Brookfield Finance Inc., an indirect 100% owned subsidiary of Brookfield, and will be fully and unconditionally guaranteed by Brookfield. The net proceeds from the sale of the notes will be used for general corporate purposes. The offering is expected to close on March 3, 2025, subject to the satisfaction of customary closing conditions.The notes are being offered under Brookfield and the issuer's existing base shelf prospectus filed in the United States and...
Nasdaq GlobeNewswire
27/02/2025

Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and…

- Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling; expected to be substantially enrolled by YE25- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial ongoing with clinical data update planned for 1H25- Petosemtamab evaluation in mCRC ongoing in combination with standard chemotherapy in 1L and 2L and monotherapy in 3L+; mCRC...
Nasdaq GlobeNewswire
27/02/2025

Amlan International to Showcase Science-Backed Feed Additives for Gut Health and…

At booth 2-2842, Amlan's leadership, technical experts and regional sales team will showcase its innovative natural feed additives, including Phylox®, Calibrin®-Z, and Varium® (available in select international markets). These products are designed to optimize gut health, mitigate disease challenges, improve feed efficiency, and enhance poultry and livestock performance.“Asia plays a vital role in the global food supply, producing about 60% of the world's poultry, including eggs. In 2022,...
Nasdaq GlobeNewswire
27/02/2025

FDA approves ODACTRA® for the treatment of house dust mite allergy in young…

ALK ( ALKB:DC / OMX: ALK B ) today announced that the US Food and Drug Administration (FDA) has approved ALK's ODACTRA ®tablet for use in young children with house dust mite (HDM) allergy. ODACTRA ®is now indicated to treat HDM-induced allergic rhinitis, with or without conjunctivitis, in children aged five through 11, in addition to patients aged 12 through 65. ODACTRA ®is an allergy immunotherapy (AIT) tablet which dissolves under the tongue and helps patients reduce their allergy...
Nasdaq GlobeNewswire
27/02/2025

Bias Capital Cancels $25 Million Investment in Parker Health Amid Serious Fraud…

Bias Capital has canceled its $25 million Series A investment in Parker Health . This action follows alarming findings during our due diligence process, which raised serious concerns about potential fraudulent activities, including misleading financial disclosures and operational irregularities.Investigations have uncovered significant issues regarding the operational integrity and financial transparency of Parker Health, founded by Vincent Lopez, a CEO recognized in Forbes' 30 Under...
Nasdaq GlobeNewswire
27/02/2025

Transaction in Own Shares

Transaction in Own Shares 27 February, 2025• • • • • • • • • • • • • • • •Shell plc (the 'Company') announces that on 27 February 2025 it purchased the following number of Shares for cancellation.Aggregated information on Shares purchased according to trading venue:Date of purchaseNumber of Shares purchasedHighest price paidLowest price paid Volume weighted average price paid per shareVenueCurrency27/02/2025694,416 £ 26...
Nasdaq GlobeNewswire
27/02/2025

Discuss Announces 3 AI Agents Built for Market Insights

Enabling 'always-on' customer and user feedback with an agentic approach Discuss, the leading end-to-end global market insights platform today announced its 3 AI Agents that deliver 'always-on', in-depth market insights, helping marketers win in the current relationship economy where emotional connections are the new currency. For decades, third-party 'agents', usually ad or marketing agencies, have been used for delivering market insights, which is typically expensive and can take...
Nasdaq GlobeNewswire
27/02/2025

Facephi Unveils "Know Your Passenger" (KYP) at IATA's World Data Symposium

Facephi Unveils "Know Your Passenger" (KYP) to Unlock Seamless Air Travel with Digital Identity at IATA's World Data Symposium KYP enables the customisation of all processes ​in a 100% secure digital environment; integrating verifiable credentials, advanced biometrics, and digital wallets to enhance security and streamline the passenger experience.Following the success of its digital travel trial between Hong Kong and Narita (Tokyo), KYP enables seamless air travel without physical...
Nasdaq GlobeNewswire
27/02/2025

Strengthening of Investor Focus – BioPorto enters Market Maker Agreement with…

February 27, 2025 Announcement no. 03Strengthening of Investor Focus – BioPorto enters Market Maker Agreement with Danske Bank & appoints New Head of Investor Relations COPENHAGEN, DENMARK, February 27, 2025, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), today announced that it has entered into a Market Maker Agreement with Danske Bank...
Nasdaq GlobeNewswire
27/02/2025

Viridien Announces its Q4 & Full Year 2024 Results

Paris (France), February 27 th, 2025, 17h45 CET2024: A YEAR OF OVERACHIEVEMENTS2025: ON TRACK TO DELIVER c .$100 MILLION NET CASH FLOW Q4FY 1 Revenue 2 $339M $ 1,117M (-1%)Adjusted EBITDA 3 $157M $455M (+14%)Net Cash-Flow$27M$56M (+73%) Sophie Zurquiyah,Chief Executive Officerof Viridien, said:“In 2024, we met our revenue and exceeded our profitability and cash generation...
Nasdaq GlobeNewswire
27/02/2025

Workplace Options' Psychological Safety Study Reveals Alarming Trends in…

WPO Centre for Organizational Effectiveness,released its annual Psychological Safety Study . The study's results reveal how employees, across 18 countries, are struggling in ways that, if left unaddressed, could define the future of work for generations to come.“Company leaders and people managers face an urgent question: Will they create a psychologically safe and engaged workforce, or will they perpetuate a culture of stress and instability,” said Alan King, President and CEO,...
Nasdaq GlobeNewswire
27/02/2025

21Shares AG (the “Company”) – Announcement: Filing of Amendment Request…

This Announcement relates to the following Exchange Traded Products entered the Official List of the FCA and admitted to the London Stock Exchange:ETP:21Shares Bitcoin ETPISIN:CH0454664001TIDM:ABTC / BTCU ETP:21Shares Ethereum Staking ETPISIN:CH0454664027TIDM:AETH / ETHU ETP:21Shares Bitcoin Core ETPISIN:CH1199067674TIDM:CBTC / CBTUETP:21Shares Ethereum Core Staking ETPISIN:CH1209763130TIDM:ETHC/ CETU (hereinafter referred to as the “...
Nasdaq GlobeNewswire
27/02/2025

AI-Media Partners with the England and Wales Cricket Board for Cutting-Edge…

AI-Media began working with the ECB to create a tailored workflow delivering live captions on LED displays at cricket stadiums across the UK to ensure accessibility during England internationals. Using AI-Media'sEncoder Pro (HD492)andAI-Live platform, the bespoke workflow ensures seamless audio input and live captions for cricket events. By leveraging AI-Media's expertise in Topic Modelling, the ECB enhanced the accuracy of their captions and now easily self-manages theirLEXIusage...
Nasdaq GlobeNewswire
27/02/2025

Zoom and Mitel announce rollout of AI-first hybrid communications and…

Jointly developed, globally available solution combines Zoom's seamless AI-first collaboration experience with Mitel's enterprise-grade telephony reliability and resiliency through a single application Zoom Communications, Inc. (NASDAQ: ZM) and Mitel , a global leader in business communications, announced the global launch of a unique hybrid cloud solution that integrates Zoom Workplace and Zoom AI Companion with Mitel's flagship communications platforms, including its leading...
Nasdaq GlobeNewswire
27/02/2025

Alira Health Oversees the Digital Development of Gustave Roussy's Project…

SpherePX Technology Powers Early Detection and Personalized Prevention The objective of Project Interception is to reduce the risk of stage 2 or higher (or equivalent) malignant tumors by 30% over five years by identifying individuals at increased risk of cancer as early as possible and offering them a personalized course of screening and prevention. Research shows that up to 40% of cancer cases are preventable, yet traditional screening methods often fail to address individual risk factors...
Nasdaq GlobeNewswire
27/02/2025

Tealium releases new product innovations: AIStream™, Consent 2.0, and advanced…

Organizations can now accelerate AI outcomes, all while honoring global data privacy requirements Tealium , the leading intelligent real-time data streaming platform, today announced new product innovations, including AIStream™ and Consent 2.0, to allow global enterprises to accelerate AI outcomes and better adapt to changing data privacy requirements. Tealium's AIStream™ fuels AI models with high-quality data which empowers enterprises with enhanced predictive insights. As a...
Nasdaq GlobeNewswire
27/02/2025

ZenaTech's ZenaDrone Advances IQ Square Drone to Manufacturing Stage for Outdoor…

“The IQ Square's rapid progression from the prototype stage, initiated in 2022, to the manufacturing and assembly stage is a testament to our hardware and engineering team's dedication and hard work. We see many commercial and government applications for the IQ Square, which we also envision will be central to powering our future DaaS operations as a versatile multifunction drone for multiple outdoor uses requiring line-of-site including fast growth uses like power washing,” said CEO Shaun...
Nasdaq GlobeNewswire
27/02/2025
Altri  Comunicati